Cart
sales@molnova.com
Protein Kinase C Substrate, Glycogen Synthase (1-8)
CAS No. ———
Protein Kinase C Substrate, Glycogen Synthase (1-8)( ——— )
Catalog No. M41696 CAS No. ———
Protein Kinase C Substrate, Glycogen Synthase (1-8)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameProtein Kinase C Substrate, Glycogen Synthase (1-8)
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtein Kinase C Substrate, Glycogen Synthase (1-8)
-
DescriptionProtein Kinase C Substrate, Glycogen Synthase (1-8)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1269.6
-
Molecular FormulaC56H104N18O15
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FQI 1
FQI 1 is a selective late-stage SV40 factor (LSF) inhibitor with anticancer activity that exerts its antiproliferative activity by disrupting the mitotic spindle.
-
CCG-63802
CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins.
-
Chrysin 6-C-glucosid...
Chrysin 6-C-glucoside 8-C-arabinoside and Chrysin-6-C-arabinosyl-8-C-glucoside are α±-glucosidase inhibitors, α±-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.
